Torvacard - nā ʻōlelo aʻoaʻo no ka hoʻohana, hoʻokuʻu i nā palapala, hōʻike, nā hopena ʻaoʻao, nā analogues a me nā kumukūʻai

ʻO kahi mea hana e pono ai i ka hakakā me atherosclerosis ʻo Torvacard. Ke hoʻohaʻahaʻa nei ia i ka kolamu nui a 30-46%, lipoprotein haʻahaʻa haʻahaʻa ma 40-60%, a hoʻoemi i ka triglycerides. Hoʻol pinepine pinepine e pale i ka myocardial infarction me ke koko koko kiʻekiʻe, maʻi maʻi vascular peripheral, maʻi puʻuwai coronary, a me nā ala āpau cardiovascular. ʻOi aku ka maikaʻi o ka lāʻau no ka maʻi maʻi.

He aha ka Torvacard

ʻO ka mea hana o Torvacard ka hale kūʻai ʻo Czechese Zentiva. Hoʻomaopopo ka mea hana i nā lāʻau lapaʻau lipid-kaila, i alakaʻi ʻia ka hana e kūʻē i nā lipoproteins density low (LDL), e hali ana i ka cholesterol ma ke kino. I kēia hopena, hōʻemi ʻo Torvacard i ka nui o ka kolamu ma ke kino (ʻo ka hoʻokaʻanaha ʻia i manaʻo ʻia ma kāna ʻano "maikaʻi ʻole" ʻo 36-54%), no laila ua pili nā lāʻau lapaʻau i ka papa o nā statins.

No ka cholesterol ma ka momona alcohols a lawe i ka mea ikaika i nā hana he nui i lawe i ke kino: he mea kōkua i ka hoʻokumu ʻana o ka vitamin D, ka hana ʻana o nā momona bile, nā hormones steroid, a genital. Hoʻokumu ʻia ka hapaweleka o ka kolamu e ke kino, ke koena e hele mai me ka meaʻai. ʻAʻole hoʻoheheʻe ʻia ka waiwai i ka wai, a no laila ʻaʻole hiki ke komo i nā pūpū me nā kahawai koko. No ka hana ʻana i kēia, ua hui pū ʻia me nā protein o kaʻohana, hana i nā lipoproteins o nā papena ʻole.

Ua hōʻea ʻo Cholesterol i nā ʻoihana kūpono ma ke ʻano o ka LDL, ʻoiai ʻo ia ke hana koʻikoʻi, ua kapa ʻia ʻo "cholesterol maikaʻi" no ka mea e hoʻolōʻihi ʻia nā pā o nā kahe koko. ʻO ka lipoproteins kiʻekiʻe, ʻo HDL, ka mea i ʻike ʻia he kolesterol maikaʻi, ke kuleana no ka hoʻoneʻe ʻana i ka kolamu mai ke kino a hoʻomaʻemaʻe i nā paia vascular. ʻO kahi kiʻekiʻe o HDL kahi hiʻohiʻona o kahi kino olakino.

Inā kiʻekiʻe loa ke kaila o LDL i ke koko, ua hoʻopau ka "cholesterol maikaʻi" i ka hana me kā lākou mau hana. A ke kumu, waiho ʻia nā kolika kolesterol ma nā paia vascular, e alakaʻi ai i ka pani ʻia ʻana o ke kahe koko ma muli o ka hoʻopili ʻana i ka lumen o nā kīʻaha koko. Hoʻopilikia pinepine nā ʻōpala i nā paia o nā veins a me nā lāʻau, e hōʻeha nei i nā ʻano o nā māka koko, ke ʻano nei e hoʻomaka ana nā platelets a me nā mea ʻē aʻe e hoʻōla ai i ka hōʻeha.

ʻO ka hele ʻana o ka manawa, ʻoi aku ka paʻakikī o nā palakolo cholesterol a hoʻololi i nā kiko vascular olakino, ʻo ia ke kumu e nalowale ai nā uha, veins, capillaries i kā lākou elasticity. Ma lalo o ka ikaika o ke kahe a ke koko, ka mea pinepine lākou e uhaʻi, e hōʻalo i ka nui a me ka liʻiliʻi. Inā hele ka hemorrhage ma ka wahi o ka puʻuwai a i ʻole ka palaka, e hele mai kekahi puʻuwai puʻuwai. ʻOiai me ka kōkua manawa kūpono, hiki paha ke make.

No ka hōʻemi i ka synthesis o kolesterol, ua hoʻoneʻe ʻo Torvacard i ka hana o ka hoʻoneʻe o ka enzyme HMG-CoA, kahi i komo i ka hana o nā momona momona. Ke alakaʻi nei kēia i kahi emi i kona synt synt, a me ka hoʻoemi ʻana i ka helu o ka lipoproteins haʻahaʻa haʻahaʻa. Me LDL, hoʻemi ʻia ka triglycerides - kahi ʻano o ka momona e hāʻawi ai i ke kino me ka ikehu a pili i ka hoʻokumu ʻana o lipoproteins. ʻO ka mea hoʻohui ʻo ia ka nui o ka "cholesterol maikaʻi" ma lalo o ka mana o Torvacard e hoʻonui.

Nā ʻōkuhi no ka hoʻohana Torvacard

I ka wā o ka hoʻomehana, pono ka mea maʻi e hahai i kaʻai e kuhikuhi ana i ka hoʻemi ʻana i nā pae lipid. Hiki iā ʻoe ke hoʻohana i ka lāʻau lapaʻau me ka meaʻai a ma kahi ʻōpū ʻole. ʻO ka lawe ʻana i Torvacard i ka wā pāʻina e hoʻolōʻihi i ka kaʻina o ke kahe ʻana, akā ʻaʻole e emi ka hopena o ka lāʻau lapaʻau no kēia. Ma mua o ka mālamaʻana, pono ia e lawe i kahi loiloi no ka pae o nā lipids i ke koko, ma kahi o nā hoʻokolohua pono.

ʻO ka paona nui loa o ka lāʻau i loko o ka plasma ua nānā ʻia i hoʻokahi hola a i ʻole ʻelua ma hope o ka hoʻohana ʻana. 98% o ka hana ikaika ma hope o ke komo ʻana i ke koko e hoʻopili ana i kāna mau protein a hoʻomau i ka hana. ʻO ka hapa nui o Torvacard e waiho i ke kino ma ke ʻāpana o ka bile ma hope o ka hoʻoili ʻana o ka ate. Me ka urine, ʻaʻole eʻoi aku ma mua o ʻelua mau pakeneka. ʻO ke kāpae hapa-ola he 14 mau hola.

Hiki i Torvacard ke pani i ka hana o ka hoʻoneʻe HMG-CoA i hoʻoneʻe ʻia ma muli o kāna atorvastatin. Hoʻokuʻu ka lāʻau i nā papa, i kēlā me kēia - 10, 20 a 40 mg o kēia mea ikaika. Hoʻokahi i hoʻokahi pahu he 30 a 90 mau papa. Hoʻohui i nā mea ikaika, keʻano o ka lāʻau lapaʻau e pili ana:

microcrystalline cellulose - hoʻonui i ka hoʻoneʻe o ka digestive, hōʻemi i ka hoʻoliʻi ʻana o ka kolamu a me ka glucose, hoʻopaʻa i nā mea i hiki ʻole.
magnesium oxide - hōʻemi i ka waikawa, e hoʻoikaika i ka ikaika o ka iwi, hoʻomaikaʻi i ka hana o ka puʻuwai, nā ʻuna, nā aʻa nīneo,
ka silicon dioxide - kahi enterosorbent e hoʻopili ana i nā toxins, allergens, bacteria a me nā mea hoʻomehana metabolic hou aʻe,
criumarmellose sodium - kōkua i ka papa maʻa koke i ka wā e hoʻoili ai ke ʻano,
magnesium stearate - paipai i ka hoʻokumu ʻana o ka hoʻomoʻa homogeneous i ka hana ʻana i nā papa,
hôkelokulana cellulose -
lactose monohydrate he mea hoʻopihapiha.

ʻO kahi lipids toto kiʻekiʻe (hyperlipidemia) kahi hōʻailona no ke koho ʻana iā Torvacard. Lawe i ka lāʻau lapaʻau i ka ʻokoʻa me kahi meaʻai e hoʻohaʻahaʻa i nā lipoproteins haʻahaʻa haʻahaʻa a me nā triglycerides, hoʻonui i ka nui o ka "cholesterol maikaʻi." Ua kuhikuhi ʻia ʻo Torvacard i kēia mau kūlana:

kiʻekiʻe ka haʻahaʻa o ka triglycerides i ke koko (hypertriglyceridemia),
dysbetalipoproteinemia,
hoʻohui hypertriglyceridemia a me hypercholesterolemia (kiʻekiʻe cholesterol),
heterozygous (pae mua) a homozygous piliona hypercholesterolemia, inā maikaʻi ʻole ka ʻai,
nā maʻi o ka ʻōnaehana cardiovascular ma mua o ka maʻi o ka dyslipidemia (kaʻe hewa ʻana o ka pae o nā lipids koko) no ka mālama ʻana i ka hōʻeha a me ka infococote myocardial.

Me ka maʻi puʻuwai coronary i kuhikuhi ʻia, ua ʻōlelo ʻia nā papa Torvacard no ka pale ʻana i ka hōʻeha ʻana a me ka hōʻeha ʻana o ka puʻuwai, hoʻomaʻamaʻa i nā ʻōnaehana hoʻolaʻa vaskular (revascularization), a me ka hoʻohaʻahaʻa i ka maʻi o ka hoʻokipa ma mua o ka puʻuwai puʻuwai. E kau i kahi lāʻau lapaʻau inā ʻaʻohe hōʻailona o ka maʻi naʻau coronary (CHD), akā aia nā mana no kona ʻano:

koko koko kiʻekiʻe
ulaula
haʻahaʻa haʻahaʻa o ka cholesterol maikaʻi
ma luna o 55 makahiki
predisposition hoʻoilina.

I mea e pale ai i kahi hōʻeha, ua ʻōlelo ʻia ʻo Torvacard no nā maʻi maʻi type 2 ʻaʻole i loaʻa ka hōʻailona o ka maʻi naʻau coronary, akā he hypertension, retinopathy (hōʻeha i ka retina), ka protein i loko o ka urine (albuminuria), e hōʻike ana i nā pilikia o ka lolo. E hoʻomoʻa i ka lāʻau lapaʻau inā poma ka maʻi maʻi. Pono e hoʻomanaʻo hiki i ka atorvastatin hiki i nā maʻi diabetes i nā poʻe i loaʻa no kēia maʻi, a ma ka hoʻomehana maʻi hoʻonui ʻia ka nui o ka glucose. No kēia kumu, pono ʻoe e lawe i ka lāʻau lapaʻau Torvard, e nānā pono ana i nā ʻōlelo a ke kauka.

Hoʻomaka ka Therapy ma kahi o ka 10 mg i kēlā me kēia lā, e piʻi mālie ana i 20 mg. ʻAʻole hiki iā ʻoe ke lawe hou ma mua o 80 mg o ka lāʻau lapaʻau i ka lā. Koho ʻia ka maʻi lā e ke kauka, me ka noʻonoʻo ʻana i nā mea pili, nā ʻano pilikino o ka mea maʻi. No nā mea maʻi me ka hypercholesterolemia homozygous, ua kūpono loa ka nui o ka 80 mg. Hoʻoholo ʻia ka lōʻihi o ke papa o ka hopena ma ke kauka. Kūpono kekahi hopena ʻike i ʻelua mau pule ma hope o ke ʻano mua. I hoʻokahi mahina ma hope o ka hoʻomaka ʻana o ka mālama ʻana, pono e hoʻopili ʻia nā hoʻokolohua no nā lipids koko a pono hoʻi ke hoʻoponopono ʻia ka hoʻoponopono lāʻau.

Nā Hoʻohui

Hoʻopili ʻia ka Torvacard i ka ate ma mua o ka haʻalele ʻana i ke kino, no laila ke contongo a ka lāʻau lapaʻau inā he mau maʻi koʻikoʻi o kēia ʻōpū. ʻAʻole hiki iā ʻoe ke lawe i ka lāʻau me ka:

ka pae o ka transaminases - nā kāpena i kuleana no ka metabolism i loko o ke kino, ke ʻano o ka manaʻo pinepine e hoʻonui me nā maʻi ate.
he kuʻuna nā kuleana no ka lactose, glucose, ka hemahema o ka lactase,
makahiki i 18 makahiki
allergy i kēlā me kēia mea o ka lāʻau.

Mai kuhikuhi i ka Torvacard i nā wahine o ka makahiki o ka hānau ʻana ʻaʻole i hoʻohana i ka contraception: hiki i nā stins ke hōʻeha i ke kino o kahi pēpē. I ka wā hāpai, ua hoʻonui mau ʻia ka ʻike ʻana o ka kolamu a me ka triglycerides, ʻoiai ua lawa kēia mau mea no ka hoʻopiha piha ʻana o ka pūpū. ʻAʻole i lawe ʻia nā haʻawina e pili ana i ka hopena o ka lāʻau lapaʻau i nā pēpē, akā ʻike ʻia ka hiki i nā statins i hiki ke komo i loko o ka waiū umauma a hoʻonāukiuki i nā hopena ʻaoʻao i kahi pēpē i ka wā o ka lactation.

Ua kuhikuhi maikaʻi ʻia ʻo Torvacard i nā pilikia me ka metabolism, ka pae wai-electrolyte, a me ke koko kiʻekiʻe. Alakika, nā mākia, maʻi o ka maʻi mellitus, epilepsy, nā hōʻeha hou, ke hōʻuluʻulu koʻikoʻi ke koi ʻana i ka lawelawe ʻana i ka wā e hoʻohana ai ka lāʻau, pili pono i ka pau a me ka hoʻoponopono regimen.

Nā hopena hopena

ʻO ka lawe ʻana i Torvacard hiki i nā hopena ʻaoʻao. Mai ka pūnao pili ʻana i hiki ke nānā ʻia:

ʻōpala
poʻomanaʻo
manaʻo ʻino
paresthesia - kahi ʻano o ka maʻi paleka e hōʻailona me ka puhi ʻana, tingling, goosebumps,
ataxia - kahi kuʻe o ka ʻākoakoa ʻana o nā neʻe o nā ʻuhane like ʻole,
ʻO ka neuropathy kahi pāpale degenerative-dystrophic o nā palu o ka nano o ke ʻano ʻole-maʻi.

Aia paha he pilikia me ka pūnaʻi ʻana o ka ʻōpala: ʻeha i loko o ka ʻōpū, ka puʻuwai, ka luaʻi, ka ʻōpū a i ʻole ka constipation, hoʻololi i ka ʻono, ka dyspepsia (paʻakikī a hōʻeha i ka ʻeha ʻana). ʻO ka hepatitis, jaundice, ka pancreatitis e hiki mai paha. Hiki i ka ʻōnaehana musculoskeletal ke pane i Torvacard - nā māka, nā ʻeha ma nā ʻeha a me nā ʻili, ke kua, myositis (ke kuʻi ʻana o nā mea hōʻeha kino).

I waena o nā hopena kūpono o ka lāʻau lapaʻau, ʻo ka ʻeha o ka umauma, nā tinnitus, ka lauoho lauoho, ka nāwaliwali, ka hoʻonui nui ʻana. I kekahi manawa hele mai kaʻeha, i loko o nā kāne - nā impotence. Hoʻokomo i kahi alaloa i Torvacard iā ia iho e like me ka urticaria, kele, ʻulaʻula a ka ʻula, ka ʻūlū, ka pupuhi. Hiki i kahi hoʻokolohua koko ke hōʻike i ka emi ʻana o ka helu platelet, kahi hoʻonui i ka hana o nā huina o nā huina o nā huina, nā mea haku o ka phosphokinase, a me nā maʻi o ka glucose.

Pono ka hoʻokele ʻana ʻo Torvacard me nā lāʻau ʻē aʻe i ke kūkākūkā me ke kauka e pale ai i nā hopena ʻaoʻao. He pōʻino hiki i ka hoʻohui pū ʻana i ka atorvastatin me nā lāʻau lapaʻau e hoʻonui ai i kona neʻe: e like ka hui like i mea e hoʻonāukiuki ai i ka rhabdomyolysis (hōʻino i nā ʻāwili o nā iwi. Inā lawe ka mea maʻi i kēlā mau lāʻau lapaʻau, kuhikuhi ke kauka i ka liʻiliʻi loa o Torvacard i ka mea maʻi ma lalo o ka mālama mau ʻana.

ʻO ka wehewehe a me nā ʻano

ʻO nā papa i ʻaina, biconvex. Ua pāpaʻi lākou me ke ʻano ʻulaʻula keʻokeʻo a ʻulaʻula paha.

ʻOi ka waiwai ikaika e loaʻa ana i ka calcium atorvastatin. Aia nā huaʻōlelo i loko o nā mea hou aʻe:

magnesium oxide
MCC
waiū waiū
Aerosil
sodium polio
E 572,
hyprolose haʻahaʻa haʻahaʻa.

Kūkulu ʻia ka lāi e nā mea:

haniailahion,
propylene glycol 6000,
ka leʻaleʻa talcum
keʻokeʻo titanium.

Hoʻomili hou a me ke ʻano hoʻohālikelike

ʻO ka lāʻau Torvacard e pili ana i ka pūʻulu hypolipidemic o nā lāʻau lapaʻau, statins. E like me ka wehewehe i loko o nā kuhikuhi, he mea pale o HMG-CoA reductase enzyme e hoʻololi i ka substrate i loko o ka mevalonic acid. Kākoʻo o GMG-CoA-hōʻano hou ka hoʻoneʻe ʻana i kahi 21-29 mau hola ma muli o ke kahe ana o nā molekele ma hope o ka hana hepatic. ʻO ka mea hana nui, e like me nā ʻōlelo a ka papa inoa o nā lāʻau lapaʻau (RLS) i ka calcium atorvastatin. ʻO nā mea kōkua e loaʻa i ka magnesium oxide, silicon dioxide, monactate lactose, hydroxypropyl a me nā cellulose microcrystalline.

ʻO ka hana pharmacological nui o ka torvacard i nā ʻōlelo kuhikuhi hoʻohemo i ka LDL synthes i ka pepi, a ma kahi o kahi - ulu mau i ka hana o ka launa pū me nā mea mālama i kēia hapa o ka cholesterol. ʻO ke ʻano o ka hana ʻana i kēia lāʻau lapaʻau nā papa, hui ʻia ma luna, ma ke ʻano e like me nā capsules. Loaʻa i ʻekolu koho koho - Torvacard 10 mg, Torvacard 20 mg, Torvacard 40 mg.

Ke hana lāʻau lapaʻau o Torvacard

ʻO Torvacard kahi lāʻau lapaʻau e pili ana i ka hui o nā lāʻau lipid-hoʻokuʻu i lalo. Hāʻawi kēia i ka hoʻohaʻahaʻa ʻana i ka nui o nā lipids i loko o ke koko, a ʻo ka mea mua, e hoʻohaʻahaʻa i ka cholesterol.

Ua hoʻokaʻawale ʻia nā lākōloko haʻahaʻa ma loko o nā ʻāpana he nui, a ʻo Torvakard no ka hui i kapa ʻia he statins. He mea koho koho hoʻokūkū koho o HMG-CoA reductase.

ʻO ka HMG-CoA reductase kahi enzyme e pili pono i ka hoʻololi ʻana o ka 3-hydroxy-3-methylglutaryl coenzyme A i ka mevalonic acid. ʻO ka waona Mevalonic he ʻano kolamu precursor.

ʻO ka ʻano o nā hana o Torvacard ka mea i keakea ʻia, ʻo ia hoʻi, ke kāohi nei i kēia hoʻololi, e hoʻokūkū ana a me ke kāohi ʻana i ka hoʻoneʻe ʻana o HMG-CoA. Ua ʻike ʻia ʻo ka cholesterol, a me ka triglycerides pū kekahi, i pili i ka lipoproteins density haʻahaʻa loa, a laila huli ʻia i loko o nā lipoproteins haʻahaʻa haʻahaʻa, e launa pū ana me kā lākou mea hoʻohana kūikawā.

ʻO ka mea hana o Torvacard - atorvastatin - ke kuleana no ka hoʻohaʻahaʻa ʻana i ka kolamu a me ka lipoproteins density haʻahaʻa a haʻahaʻa loa, a kōkua i ke hoʻonui ʻana i nā lipoprotein haʻahaʻa haʻahaʻa ma loko o ka pūpū, ma nā wahi papa, e pili ana i ka wikiwiki o kā lākou huki a hōʻoki ʻana.

ʻO ka Torvacard e hōʻemi i ka hana ʻana o nā lipoproteins haʻahaʻa haʻahaʻa i nā mea maʻi e hōʻeha nei i kahi maʻi e like me ka homchzygous familial hypercholesterolemia, ka mea paʻakikī loa ka mālama ʻana me ka lāʻau lapaʻau.

Eia kekahi, kōkua ka lāʻau lapaʻau e hoʻonui i ka nui o nā lipoproteins density kiʻekiʻe e kuleana ana no ka hoʻokumu ʻana i ke kolamu "maikaʻi".

Pharmacokinetics a me ka lāʻau lapaʻau

ʻO ka Pharmacokinetics kēlā mau loli e kū pono ana me ka lāʻau lapaʻau ponoʻī i loko o ke kino o ke kanaka. ʻO kona hāpona, ʻo ia hoʻi, ʻo ia hoʻi nā mākaukau. Pēlā nō, wikiwiki koke ka lāʻau lapaʻau i kona hiki ʻana i ke koko ma hope o hoʻokahi a hiki i ʻelua mau hola. Eia kekahi, i nā wahine, ʻoi aku ka wikiwiki o ka hiki ke piʻi ka nui o ke koʻikoʻi ma o 20%. I ka poʻe e hōʻeha nei i ka cirrhosis o ka ate ma muli o ka waiʻona, ʻo ka neʻe ponoʻī he 16 mau manawa ma mua o ke ʻano, a me ka manawa o ka loaʻa ʻana he 11 mau manawa.

ʻO ka helu o ka absorption o Torvacard e pili pono ana i ka hoʻokomo ʻana i ka meaʻai, no ka mea e hoʻolohi ana i ka lilo ʻana o nā mea hoʻoluhi, akā ʻaʻole ia e pili i ka hōʻemi o ka lipoprotein cholesterol haʻahaʻa. Inā lawe ʻoe i ka lāʻau lapaʻau i ke ahiahi, ma mua o ka hiamoe, a laila ʻoi ʻia kona paʻa ʻana i ke koko, ʻaʻole like i ka wanaʻao kakahiaka, e haʻahaʻa loa ia. Ua ʻike ʻia nō ʻoi ka nui o ka loaʻa ʻana o ka lāʻau lapaʻau, ʻo ka wikiwiki e hoʻoulu ʻia.

ʻO ka bioavailability o Torvacard he 12% ma muli o kona kahele ʻana ma o ka membrane mucous o ka digestive system a me ke kahe o ka ate, kahi i hoʻokaʻawale ʻia.

ʻO ka lāʻau pili kokoke i 100% pili i nā protein plasma. Ma hope o ka hoʻololi iki ʻana i ka ate ma muli o ka hana o nā isoenzymes kūikawā, kū i nā metabolites ikaika, ka hopena nui o Torvacard - kālai lākou i ka HMG-CoA reductase.

Ma hope o ke hoʻololi ʻana i kekahi o nā palu i loko o ke ake, ka lāʻau me ka bile e komo i loko o ka ʻōpū, ma o ia mea ua hoʻopau ʻia mai ke kino aku. ʻO ka hapalua o ka ola o Torvacard - ka manawa o ka hoʻokaʻina o ka lāʻau lapaʻau ma ke kino e hoʻēmi i ka manawa 2 mau manawa - he 14 mau hola.

Hoʻomaopopo ka hopena o ka lāʻau no kahi lā ma muli o ka hana o nā metabolites i koe.I loko o ka urine, hiki ke ʻike ʻia kahi liʻiliʻi o ka lāʻau lapaʻau.

Pono ia e noʻonoʻo i ka wā o ka hemodialysis ʻaʻole ia i hōʻike ʻia.

Nā hōʻailona no ka hoʻohanaʻana i ka lāʻau lapaʻau

He nui nā hōʻailona o Torvacard i nā hōʻailona.

Pono e nānā ʻia he papa inoa piha o ka lāʻau lapaʻau i ka papa inoa o nā hōʻike, i noʻonoʻo ʻia i ka wā i kuhikuhi ai i ka lāʻau lapaʻau.

Hōʻike nā ʻōlelo no ka hoʻohana ʻana i nā hihia āpau o ka hoʻohana lāʻau ʻana.

I waena o lākou, ʻo nā mea nui:

Ua kuhikuhi ʻia ʻo Torvacard e hōʻemi i ka kolamu ka nui, a me ka pili ʻana i ka lipoproteins haʻahaʻa haʻahaʻa, e hoʻohaʻahaʻa i ka apolipoprotein B, nā triglycerides hoʻi, a me ka hoʻonui ʻana i ka nui o ka lipoprotein kūloko kiʻekiʻe no nā poʻe e loaʻa ana i ka heterozygous a i ʻole hypercholesterolemia mua, a me ka type II lipidemia lipidemia . ^ E Ha yM. Hoʻomaopopo wale ka hopena ma ke ʻano o ka ʻai ʻana.
Eia kekahi, ʻo kaʻai ʻana, ua hoʻohana ʻia ʻo Torvacard i ka mālama ʻana i ka hypertriglyceridemia familial endogenous o ke ʻano ʻehā e like me Frederickson, a no ka mālama ʻana o ka dysbetalipoproteinemia o ke kolu o ka mea i mālama ʻole i kaʻai.
Hoʻohana ʻia kēia lāʻau lapaʻau e nā loea he nui e hoʻemi i ka kiʻekiʻe o ka kolamu a me ka lipoproteins density haʻahaʻa i kahi maʻi e like me ka homozygous familial hypercholesterolemia, inā nā meaʻai a me nā ʻano lāʻau lapaʻau non-pharmacological ʻaʻole i loaʻa ka hopena makemake. ʻO ka nui loa e like me ka laiki lua-laina.

Hoʻopiliʻia, hoʻohana ʻia ka lāʻau lapaʻau no nā maʻi puʻuwai a me nā vascular i loko o nā mea maʻi e hoʻonui nui nei i nā hopena no ka hoʻomohala ʻana i ka maʻi naʻau coronary. ʻOi aku kēia ma mua o 50 o kēia makahiki, hypertension, ulaula, haʻalele hypertrophy ventricular, diabetes mellitus, ʻōpū, maʻi vascular, a me ka wehe ʻana i nā maʻi naʻau coronary i nā mea aloha.

He mea nui ia me ka dyslipidemia concomitant, no ka mea e pale ai i ka hoʻomohala ʻana o ka puʻuwai hōʻeha, ka ʻeha ʻana, a me ka make nō hoʻi.

ʻO nā hopena ʻinoʻino mai ka hoʻohanaʻana i ka lāʻau lapaʻau

Ke hoʻohana nei i ka lāʻau lapaʻau i kahi mea maʻi, hiki i kahi kikoʻī o nā hopena maikaʻiʻole.

ʻO nā hopena kūpono paha e pono ai e noʻonoʻo i ka wā e koho ai i ka lāʻau lapaʻau.

ʻO kahi nui o nā hopena hopena i ka wā e hoʻohana ai i ka lāʻau lapaʻau ka mea i hoʻoili ai i ka ban laila i ka hoʻokele ponoʻī o ka lāʻau i ka wā e mālama ai. Pono ke lāʻau lapaʻau e kuhikuhi ʻia e ke kauka wale nō, i ka ʻike ʻana i nā ʻano o ke kino o ka mea maʻi.

Ke hoʻohana ʻia i ka lāʻau lapaʻau Torvakard, aia nā ʻano hoʻohua ʻano ʻē aʻe i kēia:

Pūnaehana waena o peripheral - ʻeha, dizz, lethargy, insomnia, nightmares, nā manaʻo hoʻomanaʻo, hoʻoneʻe a i ʻole ke kīlohelohe o peripheral, ʻehaʻeha, ataxia.
Pūnaehana Digestive - constipation or diarrhea, he ʻōpū o ka ʻōpū, ka ʻeha, ka lemela pālahalaha nui, ʻeha ʻana i ka ʻāpana epigastric, ke ʻano he nui i ka momona, e alakaʻi ana i ka anorexia, ʻo ia nō kekahi ala ʻē aʻe, ka ʻāwī ʻana i ka ate a me ka pancreas, jaundice ma muli o ka ʻōpala o ka huahe,
ʻŌnaehana musculoskeletal - pinepine nā ʻeha i nā ʻeha a me nā ʻāpana, myopathy, ʻeha ʻana o nā uaua o ka ʻiʻo, rhabdomyolysis, ʻeha ma ka kua, ko nā mea ʻeha e hōʻoia i nā ʻeha o nā wāwae,
Hōʻike allergic - hui kino a me ka wikiwiki ma ka ʻili, urticaria, maʻi kūlohelohe o nā ʻano koke (anaphylactic shock), nā Stevens-Johnson a me Lyell syndromes, angioedema, erythema,
Nā huaʻōlelo o ka lab Laboratory - ka nui o ka hōʻemi a hōʻemi i ka glucose koko, kahi hoʻonui i ka hana o creatiphosphokinase, alanine aminotransferase a aspartate aminotransferase, he hoʻonui i ka hemoglobin glycated,
Nā mea'ē aʻe - ka ʻehaʻeha, ka umauma o ka lalo a me luna o luna, nāpuna, ka alopecia focal, ke loaʻaʻana o ka paona, nāwaliwali maʻamau, ka hōʻemi ʻana o ka platelet, ka hāʻule ʻana o ka renal lua.

ʻO nā huaʻōlelo maikaʻiʻole i hōʻike ʻia i nā lāʻau a pau o ka pūʻulu statin e hoʻokaʻawale ʻia:

hoʻemi i ka libido
nā gynecomastia - ke ulu ʻana o nā kola mammary i nā kāne,
pilikia kino pili kino,
Hōʻikeʻike
maʻi ʻeha lohi me ke ʻano lōʻihi o ka mālama ʻana,
ke hiʻohiʻona o ka maʻi maʻi.

Pono mālama mālama kūikawā ma ka lawe ʻana iā Torvacard a me cytostatics, fibrates, antibiotics a me nā lāʻau antifungal, no ka mea, ʻaʻole lākou e kūpono pū. Hoʻopau ʻia kēia pili i ka glycosides cardiac, ʻoi aku hoʻi iā Digoxin.

Kēia mau ʻano like o Torvacard e like me Lovastatin, Rosuvastatin, Vasilip, Liprimar, Akorta, Atorvastatin, Zokor.

Hōʻikeʻike nā loiloi e pili ana i ka lāʻau lapaʻau, ʻoiai ʻo nā statins ka ʻoi loa o ka hui ʻoi aku ka lāʻau lapaʻau e hoʻohaʻahaʻa i ka kolesterol.

E haʻi nā loea i nā statins i loko o kahi wikiō ma kēia ʻatikala.

ʻĀpana Pharmacological

ʻO ka mea ikaika e koho a me ka hoʻokūkū hoʻi HMG-CoA reductase, he enzyme e pili ana i ka hana ʻana o nā steroid, me ka kolamu. Hoʻonui pū ia i ka nui o nā mea hoʻokomo LDL i loko o ka ate, e hopena ana i ka hoʻonui ʻana a me ka luku ʻana i ka LDL.

ʻAi liʻiliʻi ʻo Atorvastatin i ka nui o ka maʻi LDL i nā mea maʻi me ka hypercholesterolemia homozygous homozygous, ka mea, ʻaʻole i hiki ke mālama ʻia me nā lāʻau lapaʻau hypolipidemic.

Kuhi ka nui o ka atorvastatin i ʻike ʻia i nā hola 1-2 ma hope o ka ʻaina. Ke lawe nei i ka lāʻau lapaʻau i ke ahiahi, ʻoi aku ka ʻike o 30% ma lalo o ke kakahiaka. ʻO ka bioavailability o ka lāʻau wale nō 12%, ʻo ia ke kumu o ka hoʻololi ʻana i ka mea hana i ka membrane o ka huina a nā iʻa. I luna o 98% o ka lāʻau lapaʻau ka mea e hoʻopili ai i nā ʻōnaehana koko. Hoʻokuʻu ʻia ia mai ke kino me ka bile, ka hapalua-manawa o 14 mau hola.

No nā pākeke

Ua kuhikuhi ʻia ʻo Torasemide me ke ʻano kai.

e hōʻemi i ka hoʻonui nui ʻana o ka kolamu, nā lipoproteins haʻahaʻa haʻahaʻa, apolipoprotein B a me nā triglycerides, a me ka hoʻonui ʻana i nā ʻike o ka lipoproteins kiʻekiʻe ma nā maʻi me ka hyperlipidemia primel, he hemozygous familial a me nā nonopilial hyperlipidemia, a me nā ʻili o ka hypercholesterolemia (nā ʻano IIa a me IIon Fred
me ka piʻi o ka triglycerides (type IV like Fredrickson),
me ka dysbetalipoproteinemia (ʻano III e like me Fredrickson),
me ka homozygous hypercholesterolemia e hoʻohaʻahaʻa i ka kaila o ka kolamu a me nā lipoproteins haʻahaʻa haʻahaʻa.

Ua kuhikuhi ʻia ʻo Torasemide no nā ala e pili ana i ka ʻōnaehana cardiovascular i ka poʻe maʻi i loaʻa ka nui o ka maʻi o ka maʻi naʻau coronary - ʻoi aku ma luna o 55 mau makahiki he nui, ka hoʻohui ʻo nikotine, ke koko kiʻekiʻe, maʻi mellitus, mellitus peripheral, he mōʻaukala o ka ʻeha, ka hypertrophy ventricular, protein i loko o ka urine, maʻi maʻi coronary i nā hoahānau. nā hoahānau, ma muli o ka dyslipidemia. I kēia mau maʻi maʻi, ka lawe ʻana i ka lāʻau lapaʻau e hōʻemi i ka make o ka make, myocardial infarction, stroke, re-hospitalization ma muli o ka angina pectoris a me ka pono no ka revascularization.

ʻAʻole pono ke kuhikuhi ʻia ʻo Torvacard i nā keiki liʻiliʻi.

No ka hapai a me ka lactating

Hoʻopilikia ke Torvacard i nā mea maʻi ma ke kūlana a me ka ʻeha. ʻAʻole pono e hoʻohana ʻia ka lāʻau lapaʻau no nā wahine o ka makahiki hānau inā ʻaʻole lākou e hoʻohana i ka contraceptives kūpono. Aia nā ʻike ʻike i ka hānau hānau ʻana o nā keiki me nā pathologies congenital i ka hihia i lawe ʻia ai kā lākou manaʻo i ka wā hāpai ʻo Torvacard.

Nā hopena hopena

Hiki ke hopena i ka hopena pili kino i ka wā e mālama ai me Torvacard:

ʻO ka hōʻeha, ka luhi, ka dizziness, ke hiamoe o ka hiamoe, ka mea e hiki ke ʻike ʻia e nā moe pōkeke, ke hiamoe nei, ʻūhū, nā hoʻomanaʻo ʻana a i ʻole ka hoʻoluhi, nā kaumaha, nā polyneuropathy peripheral, hypesthesia, paresthesia, ataxia,
ʻeha a me ka ʻōpūʻeha o ka ʻōpū, nausea, ka luaʻi, ka ʻōpū, ka constipation, flatulence, hepatitis, ʻeha ʻana o ka pancreas, jaundice cholestatic, hoʻonui nui ʻia, pau ʻole ka makemake ʻana,
ʻeha a me ka ʻeha puʻuwai, ʻeha hoʻi, myopathy, hana ʻana i nā ʻuhane o ke kala, rhabdomyolysis, nā wāwae wāwae,
nā maʻi alakani, ka mea i hōʻike ʻia e kahi ʻeha, ka ʻeha ʻili, urticaria, edema Quincke, anaphylaxis, bullhes rashes, erythema multiforme exudative,
hoʻonui a hōʻemi paha i ke kahe koko,
ka hoʻonui ʻana o nā ʻike o ka hemoglobin glycosylated, ka hana o nā enzyme o nā ate,
ua ʻeha ka ʻōpū
ka popo ʻana o nā ohe
erectile dysfunction
lauoho lauoho nema
kani ana i na pepeiao
hōʻemi i ka pae o ke kō i loko o ke koko,
kōleʻa hope kūlohelohe
loaʻa ka paona
nāwaliwali a me ka maluhia.

Hoʻopili pū me nā lāʻau ʻē aʻe

Me ka hoʻokele pū ʻana o ka atorvastatin a me cyclosporine, fibrates, erythromycin, clarithromycin, immunosuppressants a me antimycotics o ka hui azole, ka waikene nikotinic a me nikotinamide, nā lāʻau hōʻemi e hoʻōla ana i ka metabolism, me ka komo ʻana o nā isoenzyme 3A4 CYP450, a me ka hoʻoulu ʻana. a me ka makiaia o myopathy. No laila, inā hiki ʻole kahi hui like ʻole, pono ʻoe e kaupaona i nā hōʻeha a me nā pono pōmaikaʻi iā ia. ʻO nā mea maʻi e loaʻa ana i ia ʻano hui hoʻohui pono ʻia ma lalo o ka mālama mālama olakino maʻamau a, inā i ʻike ʻia ka nui o ka hana kinine a me nā hōʻailona paha o ka myopathy, pono e hoʻoneʻe ʻia ʻo Torvacard.

Hoʻohaʻahaʻa ka Colestipol i ka hoʻokaʻawale o ka atorvastatin, akā ʻoi aku ka hopena o ka lipid-hoʻohaʻahaʻa ʻana o kēia hui ma mua o kēlā me kēia o kēia mau lāʻau.

Hoʻonui ka Atorvastatin i ka hopena o nā lāʻau lapaʻau e hoʻohaʻahaʻa i ka pae o nā testosterone steroid endogenous.

I ka koho ʻana i ka atorvastatin i loko o kēlā me kēia lā o ka 80 mg i ka manawa like me ka kūlohelohe waha e pili ana i ka norethindrone a me ka ethinidestraliol, he piʻi nui ka piʻi ʻana o nā contraceptive i loko o ke koko.

Ke lawe nei i ka atorvastatin i loko o kēlā me kēia lā o 80 mg me digoxin, ua nānā ʻia kahi hoʻonui o ka glycoside cardiac.

Nā ʻōlelo kikoʻī

Ma mua o ka lawe ʻana iā Torvacard, ʻo ka hoʻohaʻahaʻa i ka cholesterol he kūpono i ke ho'āʻo ʻana me kahi meaʻaiʻai, hoʻonui i ka hoʻonaninua kino, ke kaumaha ʻana i ka mea kaumaha ma nā mea maʻi me ka momona a me ka mālama ʻana i nā ala ʻē aʻe.

E pale aku i ke ʻano o ka mālama ʻana, pono e nānā ʻia ka hana ʻula, no laila pono ke nānā ʻia kona kūlana ma mua o ka hoʻomaka ʻana o Torvacard, 6 a me 12 mau pule ma hope o ka hoʻomaka ʻana o ka mālama ʻana, ma hope o ka piʻi hou ʻana o ka inikua, a no kēlā hoʻi kēia manawa, no ka manawa hoʻokahi, i kēlā me kēia mahina ʻeono. I ka wā o ka hoʻomohala, hiki ke mālama ʻia ka hana o nā huina o nā huina o ke kano, ma mua o ka 3 mau mahina o ka mālama ʻana, akā inā he hoʻomaluhi loa kēia mau ʻōmole ma mua o ka manawa he 3 mau manawa, pono ʻoe e hōʻemi i ka hoʻowalewale o ka atorvastatin a kāpae paha i ka lawe ʻana.

Eia kekahi, pono e hoʻokuʻu ʻia ka lāʻau inā loaʻa nā hōʻailona o ka myopathy, ke loaʻa ʻana o nā mea pōpilikia no ka hiki ʻole o ka renal ma muli o ka rhabdomyolysis, e like me ke kahe koko haʻahaʻa, ke ʻano aʻeha koʻikoʻi, nā hōʻeha hoʻokaumaha, nā trauma, nā hana hoʻokele ʻole, ka maʻi kūloko, ka hopena o ka endocrine.

E kū'ē i ke kua o ka lapaʻau, hoʻonui ka nui o ka glucose i ke kino, i kekahi mau mea maʻi, hiki i ka hōʻike ʻana i ka maʻi mellitus no ka maʻi, nā mea e koi ai i nā mākaʻi hypoglycemic.

ʻAʻole pili ka lāʻau lapaʻau i ka hiki ke alakaʻi i kahi kaʻa.

Nā kūlana mālama

Pono e mālama ʻo Torvacard i waho o ka hiki o nā keiki no 4 mau makahiki mai ka lā i hana ʻia ai ka lāʻau lapaʻau. Hoʻokuʻu ʻia ka lāʻau lapaʻau mai kahi lāʻau lapaʻau e like me ke kauka a ke kauka, no laila ʻaʻole lākou e ʻae ʻia e hoʻōla.

Anvistat. He lāʻau lapaʻau kēia e loaʻa ana i nā papa oblong. ʻO lākou, ʻaʻole e like me nā papa Torvacard, e pili ana ka paʻakikī, kahi kūpono no nā maʻi e hiki ʻole i ka lāʻau ʻoliʻolo nui.
Atomax ʻO ka lāʻau lapaʻau e hana ʻia e ka hui India HETERO DRUGS Limited. Loaʻa ia i ka puni, nā papa biconvex me kahi ikona. ʻO 2 mau makahiki kahi noho i ka pale o ka lāʻau.
Atorvastatin. Hoʻohui ʻia ka lāʻau lāʻau e nā hui ʻo Lūkini. Ke hoʻohaʻahaʻa nei kona kumukūʻai ma mua o Torvacard, akā ʻo ka mea i hope, hiki ke hōʻoia i ka ʻokoʻa mai ka lāʻau lapaʻau kūloko. ʻOi aku ka pōkole o ke ola o Atorvastatin ma mua o ka Torvacard, no ka laʻana, he 3 mau makahiki no ka lāʻau lapaʻau i hana ʻia e Biocom CJSC.

Hiki iā ʻoe ke lawe i ka analogue ma kahi o Torvacard wale nō ma hope o ke kūkā ʻana me ke kauka.

ʻO ka kumukūʻai o Torvacard ka awelika o 680 mau rubles. Kūʻai ʻia nā kumukūʻai mai 235 a 1670 rubles.

Hoʻohana i ka wā hāpai

ʻO ka ʻōpū me ka hoʻohana ʻana o kēia statin he contraindication. Wahi a nā ʻōlelo kuhikuhi, ʻaʻole i kuhikuhi ʻia ka lāʻau i ka wā o ka umauma, ma muli o ka ʻike ʻole ʻia ʻole e hōʻike ʻia paha ke ʻano o ka mea hana, atorvastatin, i loko o ka waiū umauma.

Wahi a nā ʻōkuhi, ʻaʻole ia i kuhikuhi ʻia ma ka lāʻau lapaʻau pediatric ma muli o ka nele o nā hōʻike hōʻike no ka noi ʻana i kēia ʻoihana.

Hoʻopili pū me nā lāʻau ʻē aʻe

ʻO ka paʻakikī o ka nānā ʻana a me ka holomua o ka myopathy i ka wā e kuhikuhi ana i nā lipid-hoʻemi haʻahaʻa i hōʻemi i ka hoʻokumu ʻana o ka kolamu e hoʻonui me ka hoʻohana pono ʻana o ka nui o nā lāʻau lapaʻau. Ma keʻano kūikawā, nā fibrates, antimicrobials (azole derivatives), cyclosporine, a me nā mea he nui o ka lāʻau lapaʻau. Aia nā ʻōlelo i ka papa inoa o nā pono hana, ka hoʻopili ʻana me nā mea he nui o nā hiʻohiʻona:

Me ka hoʻonohonoho like like o ka torvacard me phenazone a warfarin - ʻAʻole i loaʻa ka ʻike pili i kekahi mauʻoihana koʻikoʻi.
Me ka hoʻokele pū ʻana o nā lāʻau, like nā huakaʻi cyclosporine (gemfibrozil a me nā lāʻau lapaʻau ʻē aʻe o kēia hui), immunosuppressants, antimycotic agents o azole derivatives, nā lāʻau lapaʻau e hoʻoweliweli ana i ka hana metabolism me CYP450 isoenzyme 3A4, hoʻonui i ka plasma i ka Torvacard e hoʻonui. Ke nānā ʻia nei ka mālama ʻana i nā maʻi āpau a, inā pono, ʻo ke alakaʻi ʻana i nā lāʻau lapaʻau wale nō e hoʻomaka i nā inikua.
Me ka hoʻohana like ʻana o Torvacard i ka nui o 10 mg i kēlā me kēia lā azithromycin i loko o kahi helu 500 mg i kēlā me kēia lā, ʻo AUC o ka mea mua o lākou i loko o ka plasma ua loli ʻole.
Me ka hoʻohana like ʻokoʻa o kēia statin a me nā mea lapaʻau, nona ka hydroxyxides o ka manenika a me ka alumini, ka statin AUC i ke koko i hoʻemi ʻia e ka aneane 30-35%, akā ʻaʻole i loli ka hopena o ka maʻi neʻe a me ka pae o ka hōʻemi o ka LDL i ka plasma koko, ʻaʻole i loli, akā naʻe, ke kauka. e pono ai ka mana.
Colestipol. ^ E Ha yM. Pēlā nō i ka statins i aʻo ʻia i kēia lā, he mea ʻawaʻawa ia o ka lipid o ka pūʻulu o nā ʻāpana anion-exchange. Me kahi noi aloha, ua hoʻemi ʻia ke kāwili i ka plasma o Torvacard e kahi hapaha hapaha, akā ke kaʻina hopena ʻoi loa mai ka hoʻomaka ʻana o ka hoʻohana pono ʻana i nā lāʻau lapaʻau i ʻoi aku ka ʻoi ma mua o kēlā me kēia.
Nā maʻi hoʻohālikelike. ^ E Ha yM. ʻO ka kaila like ʻole o ka statin i manaʻo ʻia i kahi kiʻekiʻe (80 milligrams) me kēia mau lāʻau ke alakaʻi i kahi piʻi nui o nā pae o nā māhele o ka lāʻau. Wahi a nā ʻōlelo kuhikuhi, e ulu ana ka AUC o ka ethinyl estradiol ma 20%, a ʻo ka norethisterone e ka 30%.
Digoxin. ^ E Ha yM. ʻO ka hui pū me ka digoxin e alakaʻi i ka mea i hoʻonui ʻia ka hapa o ka torvacard plasma e 20%. ʻO ka poʻe maʻi e loaʻa ana i ka digoxin i hui pū me ka statin ma ka palena kiʻekiʻe (80 milligrams - kiʻekiʻe, hoʻoponopono ʻia e nā ʻōkuhi) e nānā mau loa ʻia.

Ka lāʻau kūʻai lāʻau

ʻO ke kumukūʻai kumukūʻai o nā lāʻau lapaʻau ma nā pale lāʻau lapaʻau e hilinaʻi ana i kona maʻi a me ka helu o nā papa i loko o kahi pā. Ma Lūkia ke kumukūʻai kumukūʻai no Torvakard ma loko o ka ʻāina:

ʻO Torvacard 10 mg - e pili ana iā 240-280 mau rubles no 30 mau papa, no 90 mau papa e hāʻawi ʻia ai ʻoe i kahi nui ma ka waihona o 700-740 rubles.
ʻO Torvacard 20 mg - e pili ana iā 360-430 mau rubles no nā papa 30 a me 1050 - 1070 rubles no 90 mau papa, ia manawa.
Torvacard 40 mg - e pili ana iā 540 - 590 mau rubles no 30 mau papa a me 1350 - 1450 mau rubles no 90 mau ʻāpana.

I Ukrainia ʻO ka māka kūʻai lapaʻau no Torvacard i loko o nā lāʻau lapaʻau e like me kēia:

ʻO Torvacard 10 mg - e pili ana iā 110-150 UAH no 30 mau papa, no 90 mau papa e pono ai ʻoe e hāʻawi i ka nui ma ka waihona o 310 - 370 UAH.
ʻO Torvacard 20 mg - e pili ana iā 90 - 110 UAH no 30 mau papa a me ka 320 - 370 UAH no 90 mau papa, ia manawa.
ʻO Torvacard 40 mg - ke ʻano like ke kumukūʻai mai 220 a 250 UAH no 30 mau papa.

Aia ke kulekele kumukūʻai e pili ana i ka ʻāina a me ka mea hana, ma luna o nā hiʻohiʻona o ke kālepa lāʻau lapaʻau, ma luna o ke kumukūʻai kumukūʻai kūloko.

Nā kikowaena Torvakard

ʻO Torvacard - kahi lāʻau lapaʻau i hoʻāʻo pono iā ia iho, e hōʻike ana i nā hopena kauka maikaʻi a ua kūpono hoʻi i ke kumu kūʻai. Eia nō naʻe, i kekahi mau hihia (intolerance pilikino, loli i loko o nā kauka lapaʻau, loli i ke ʻano o ka mea maʻi) pono paha ia e koho i kahi nūnū ma mua o kahi torvacard.

Aia nā mea pili me ka waiwai like i nā ʻōlelo aʻoaʻo, e like me Torvakard - Atorvastatin. ^ E Ha yM. ʻO kēia me Atokor, Atoris, Liprimar, Torvazin, Tulip, Livostor.

Ma kahi o lākou, hiki i nā mea lapaʻau ke koho pono i kahi hoa pāmu. he mau statins nō hoʻi ka hui. Hoʻopili kēia me nā mea kanu e like me Acorta, Rosuvastatin, Krestor, Rosucard, Rosart, Lipostat, Roxer, Simgal a me nā mea ʻē aʻe.

Nā Hōʻike Hoʻohana

Ma waena o nā kauka, e pili ana i nā loiloi torvakard Hōʻike pinepine ʻia i nā koho no ka hypercholesterolemia o nā ʻano genesis like ʻole. I nā makahiki, ua hōʻoia ka lāʻau lapaʻau i ka hana pono.

Zhilinov S.A. Endocrinologist, ʻo Ufa: "Ua lawelawe wau i ka torvacard i kaʻu poʻe maʻi no kekahi manawa. ʻIke pinepine wau i kahi hopena kūpono ʻoi aku me ka liʻiliʻi loa o nā hoʻopiʻi a i nā hopena paha. Hana maikaʻi loa ia i ka mālama ʻana i nā kūlana me ke kolamu kiʻekiʻe. Eia kekahi, i ka paleʻana o ischemia cardiac, loaʻa pū ia i kahi mea nui. A i ke kumukūʻai ua loaʻa iā ia aneʻi kekahi maʻi.

E like me nā kauka, hoʻomālamalama ka poʻe maʻi e pili ana i kēia lāʻau lapaʻau. Ke hoʻohālikelike ʻia me nā statins kaulana, e nani loa ke kumukūʻai a me ke loaʻa o ka lāʻau lapaʻau.

Vasilenko S.K., ka mea hoʻokele kaʻa hoʻokele, 50 makahiki, Kerch: “Ua loaʻa iaʻu ka kolamu i kaʻu mau ʻōlelo i ʻeono makahiki i hala. Hele wau i ka haukapila, ua kau ʻo ke kauka kūloko iā Torvakard iaʻu. I ka manawa mua ua manaʻo au ua makehewa koʻu kālā, akā laila heluhelu wau i nā ʻōlelo a ka lāʻau lapaʻau, hoʻolohe i nā ʻōlelo a ke kauka a maopopo i ka hopena ʻaʻole ia ka lula, akā lilo ka paʻila. A ma hope oʻelua pule, uaʻike wau i nā loli maikaʻi i koʻu olakino. ʻAʻohe o kēia mau ʻōlelo hoʻopiʻi, manaʻo wau iaʻu he ʻumi makahiki he ʻōpio. "

Chegoday E.A. 66 makahiki ʻo Voronezh: “Mai koʻu wā ʻōpio ua loaʻa iaʻu kahi pilikia me ka cholesterol kiʻekiʻe. Ma mua o ka lawe ʻana i ka ʻili, inu au i ka lypimar - i ka hoʻoponopono ʻana ma nā ʻōlelo kuhikuhi, he like ko lākou like me ka ʻano like. Akā ke kumu kūʻai nā kumukūʻai no ka lypimar, no laila ua ʻōlelo ke kauka e hoʻohuli wau iā ia me ka lāʻau lapaʻau maʻalahi. ʻAʻole wau iho ʻike iki ʻokoʻa kekahi hopena, ʻaʻohe hopena ʻokoʻa mai kēlā papa inoa nui i nā ʻōkuhi, ʻaʻole wau i loaʻa i ka lāʻau lapaʻau a i ʻole kēia. He mea minamina wale nō kēia e pono ke inu i kēia mau paila i koʻu ola a pau. "

Panchenko Vera, 39 makahiki, p. Antonovka: “Ua lōʻihi aku koʻu makuakāne o ka maʻi maʻamau ma ka 2, ma mua o ka hoʻōla, ka ʻike o ka glucose i ke koko ma ka ʻōpū ʻole i hiki aku i 8-9. He nui ko ia kino o ke kino, a e like me ka ʻōlelo a ke kauka, no laila ke kumu ka puka ʻana o kolesterol i nā helu. Ma ka halemai apana, ua aʻo ikaika ʻia mākou, ma kahi o kā mākou lāʻau lapaʻau āpau, e inu i 20 mau milila o ka ʻōpala i kēlā me kēia pō, e like me nā kuhikuhi. Ka mea i lilo i kūpono kūpono - pono ʻoe e inu i ka manawa hoʻokahi i ka lā. ʻO ka mea wale nō e pono ai, no ka mea, ua aneane ʻo papa he 70 mau makahiki a i kona mau makahiki he paʻakikī iā ia ke hoʻomanaʻo i nā paila āpau. Eia kekahi, ke ʻōlelo nei nā ʻōlelo e pili ana i ka lawe ʻana i nā pills ʻaʻole i hilinaʻi ʻia - he mea hāpau nui loa kēia i hāʻawi ʻia i ka maʻi diabetes. I ka malama mua loa, i ka wā i hoʻomaka ai mākou i ka inu ʻana i kēia lāʻau lapaʻau, aia kahi laʻa ʻike nui i ka nui o ka cholesterol, a i kēia manawa ua maikaʻi nā mea a pau me ia, he mea maʻamau».

E like me kāu e ʻike ai, e hoʻoponopono ʻia ana e nā loiloi o nā kauka a me kā lākou mau maʻi, ka lāʻau lapaʻau i koho ʻia i lalo - ʻo Torvacard - he hana maikaʻi loa a he mea maʻamau loa ia i ka hana lapaʻau. Hōʻike pinepine pū kekahi mau loiloi e pili ana i ka kumukūʻai kūpono o kēia statin. Pono e noʻonoʻo a hoʻomanaʻo a hiki i ka mea hiki ke kuhikuhi i ka torvacard ma hope o ka hoʻopaʻa ʻana ʻana o ka hoʻokolokolo ʻana a me ka kūkākūkā ʻana me nā poʻe loea kūpono, ma muli o kāna mau ʻōlelo kū hoʻokahi.